Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP881121.RAu4wcSq4OeA4Vnk_pMEy0SAhVlnkhCSWJ59UmLD5sdxQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP881121.RAu4wcSq4OeA4Vnk_pMEy0SAhVlnkhCSWJ59UmLD5sdxQ130_assertion type Assertion NP881121.RAu4wcSq4OeA4Vnk_pMEy0SAhVlnkhCSWJ59UmLD5sdxQ130_head.
- NP881121.RAu4wcSq4OeA4Vnk_pMEy0SAhVlnkhCSWJ59UmLD5sdxQ130_assertion description "[In contrast, out of the 97 cases of invasive ductal carcinomas studied, 90 (93%) and 96 (99%) reacted positively with BC-I and FDC-6, respectively, the reaction being observed in the tumoral stroma connective tissue and in tumoral vessels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881121.RAu4wcSq4OeA4Vnk_pMEy0SAhVlnkhCSWJ59UmLD5sdxQ130_provenance.
- NP881121.RAu4wcSq4OeA4Vnk_pMEy0SAhVlnkhCSWJ59UmLD5sdxQ130_assertion evidence source_evidence_literature NP881121.RAu4wcSq4OeA4Vnk_pMEy0SAhVlnkhCSWJ59UmLD5sdxQ130_provenance.
- NP881121.RAu4wcSq4OeA4Vnk_pMEy0SAhVlnkhCSWJ59UmLD5sdxQ130_assertion SIO_000772 7927891 NP881121.RAu4wcSq4OeA4Vnk_pMEy0SAhVlnkhCSWJ59UmLD5sdxQ130_provenance.
- NP881121.RAu4wcSq4OeA4Vnk_pMEy0SAhVlnkhCSWJ59UmLD5sdxQ130_assertion wasDerivedFrom befree-20140225 NP881121.RAu4wcSq4OeA4Vnk_pMEy0SAhVlnkhCSWJ59UmLD5sdxQ130_provenance.
- NP881121.RAu4wcSq4OeA4Vnk_pMEy0SAhVlnkhCSWJ59UmLD5sdxQ130_assertion wasGeneratedBy ECO_0000203 NP881121.RAu4wcSq4OeA4Vnk_pMEy0SAhVlnkhCSWJ59UmLD5sdxQ130_provenance.